Key points are not available for this paper at this time.
Metastatic castration-resistant prostate cancer remains fatal despite recent advances. Prostate-specific membrane antigen (PSMA) is highly expressed in metastatic castration-resistant prostate cancer. Lutetium-177 (177Lu)–PSMA-617 is a radioligand therapy that delivers beta-particle radiation to PSMA-expressing cells and the surrounding microenvironment.
Building similarity graph...
Analyzing shared references across papers
Loading...
Oliver Sartor
Johann S. de Bono
Kim N.
New England Journal of Medicine
Cornell University
Memorial Sloan Kettering Cancer Center
Oregon Health & Science University
Building similarity graph...
Analyzing shared references across papers
Loading...
Sartor et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d56c2f75589c71d767cc7a — DOI: https://doi.org/10.1056/nejmoa2107322
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: